Overall, this evidence seems to indirectly present the exhaustion characteristic of high CD39-expressing CD8+ T cells and further shows its potential as a target in combination with ICIs for the treatment of esophageal carcinoma. Here, ENTPD1 is linked to carcinoma of esophagus.